PD-1 and LAG-3-positive T cells are associated with clinical outcomes of relapsed/refractory multiple myeloma patients

被引：0
|
作者：
Ming Chen
Jinlian Zhu
Xuedong Yang
Jianxin Yao
Yuqing Liu
Qiang Liu
机构：
[1] Changshu No.2 People’s Hospital,Department of Hematology
[2] Changshu No.2 People’s Hospital,Department of Oncology
[3] Changshu No.1 People’s Hospital,Department of Hematology
来源：
European Journal of Medical Research | / 27卷
关键词：
Relapsed/refractory multiple myeloma; T cell subtype; PD-1; LAG-3;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers
    Giulia Bottai
    Carlotta Raschioni
    Agnese Losurdo
    Luca Di Tommaso
    Corrado Tinterri
    Rosalba Torrisi
    Jorge S. Reis-Filho
    Massimo Roncalli
    Christos Sotiriou
    Armando Santoro
    Alberto Mantovani
    Sherene Loi
    Libero Santarpia
    Breast Cancer Research, 18
  • [32] An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers
    Bottai, Giulia
    Raschioni, Carlotta
    Losurdo, Agnese
    Di Tommaso, Luca
    Tinterri, Corrado
    Torrisi, Rosalba
    Reis-Filho, Jorge S.
    Roncalli, Massimo
    Sotiriou, Christos
    Santoro, Armando
    Mantovani, Alberto
    Loi, Sherene
    Santarpia, Libero
    BREAST CANCER RESEARCH, 2016, 18
  • [33] Systematic Literature Review and Meta-Analysis of Clinical Trials of Fourth Line or Higher Treatment for Relapsed/Refractory Multiple Myeloma Patients
    Patel, Krina
    Sidana, Surbhi
    Hasegawa, Ken
    Itani, Taha
    Giordana, Monique
    Jackson, Carolyn C.
    Donelson, Sarah M.
    Chan, Rebecca J.
    Kostic, Ana
    Limbrick-Oldfield, Eve H.
    Zoratti, Michael J.
    Mateos, Maria-Victoria
    Hansen, Doris K.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S551 - S551
  • [34] Impact of genomic aberrations including chromosome 1 abnormalities on the outcome of patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasone
    Chang, Hong
    Jiang, Allan
    Qi, Connie
    Trieu, Young
    Chen, Christine
    Reece, Donna
    LEUKEMIA & LYMPHOMA, 2010, 51 (11) : 2084 - 2091
  • [35] Single-cell characterization of anti-LAG-3 and anti- PD-1 combination treatment in patients with melanoma
    Huuhtanen, Jani
    Kasanen, Henna
    Peltola, Katriina
    Lonnberg, Tapio
    Glumoff, Virpi
    Bruck, Oscar
    Dufva, Olli
    Peltonen, Karita
    Vikkula, Johanna
    Jokinen, Emmi
    Ilander, Mette
    Lee, Moon Hee
    Makela, Siru
    Nyakas, Marta
    Li, Bin
    Hernberg, Micaela
    Bono, Petri
    Lahdesmaki, Harri
    Kreutzman, Anna
    Mustjoki, Satu
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (06)
  • [36] Combined inhibition of PD-1/PD-L1, Lag-3, and Tim-3 axes augments antitumor immunity in gastric cancer–T cell coculture models
    Kosaku Mimura
    Ley-Fang Kua
    Jin-Fen Xiao
    Bernadette Reyna Asuncion
    Yuko Nakayama
    Nicholas Syn
    Zul Fazreen
    Richie Soong
    Koji Kono
    Wei-Peng Yong
    Gastric Cancer, 2021, 24 : 611 - 623
  • [37] Carfilzomib, dexamethasone, and daratumumab in Asian patients with relapsed or refractory multiple myeloma: post hoc subgroup analysis of the phase 3 CANDOR trial
    Suzuki, Kenshi
    Min, Chang-Ki
    Kim, Kihyun
    Lee, Je-Jung
    Shibayama, Hirohiko
    Ko, Po-Shen
    Huang, Shang-Yi
    Li, Sin-Syue
    Ding, Bifeng
    Khurana, Monica
    Iida, Shinsuke
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 114 (06) : 653 - 663
  • [38] Carfilzomib, dexamethasone, and daratumumab in Asian patients with relapsed or refractory multiple myeloma: post hoc subgroup analysis of the phase 3 CANDOR trial
    Kenshi Suzuki
    Chang-Ki Min
    Kihyun Kim
    Je-Jung Lee
    Hirohiko Shibayama
    Po-Shen Ko
    Shang-Yi Huang
    Sin-Syue Li
    Bifeng Ding
    Monica Khurana
    Shinsuke Iida
    International Journal of Hematology, 2021, 114 : 653 - 663
  • [39] Combined inhibition of PD-1/PD-L1, Lag-3, and Tim-3 axes augments antitumor immunity in gastric cancer-T cell coculture models
    Mimura, Kosaku
    Kua, Ley-Fang
    Xiao, Jin-Fen
    Asuncion, Bernadette Reyna
    Nakayama, Yuko
    Syn, Nicholas
    Fazreen, Zul
    Soong, Richie
    Kono, Koji
    Yong, Wei-Peng
    GASTRIC CANCER, 2021, 24 (03) : 611 - 623
  • [40] Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results
    Saad Z. Usmani
    Maria-Victoria Mateos
    Vania Hungria
    Shinsuke Iida
    Nizar J. Bahlis
    Hareth Nahi
    Hila Magen
    Michele Cavo
    Cyrille Hulin
    Darrell White
    Valerio De Stefano
    John Fastenau
    Mary Slavcev
    Christoph Heuck
    Xiang Qin
    Huiling Pei
    Tara Masterson
    Kristen Lantz
    Katharine S. Gries
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 619 - 631
12345